{
    "clinical_study": {
        "@rank": "63726", 
        "acronym": "HISTO-RAD", 
        "arm_group": {
            "arm_group_label": "Single arm", 
            "arm_group_type": "Other", 
            "description": "Single arm"
        }, 
        "brief_summary": {
            "textblock": "Inclusion criteria:\n\n        -  Patients with biochemical recurrence (Phoenix criteria: PSA nadir + 2 ng/ml) after\n           radiation therapy for prostate cancer addressed for prostate biopsy OR\n\n        -  Patients referred to our institution for biopsy-proven local recurrence after radiation\n           therapy for prostate cancer but needing a re-assessment with biopsy (insufficient\n           number of biopsy and/or imprecise location of positive biopsy and/or questionable\n           diagnostic of recurrence)\n\n      Study Design:\n\n        -  Included patients will undergo an endorectal US examination with a Histoscanning\u2122\n           acquisition and a multiparametric (T2-weighted, diffusion-weighted and dynamic\n           contrast-enhanced) MRI.\n\n        -  Two independent operators will separately define suspicious focal lesion on\n           Histoscanning\u2122 images and on MR images.\n\n        -  Random biopsies (at least 2 cores) will be performed in sextants negative at\n           Histoscanning\u2122 and at MRI ; In sextants positive at Histoscanning\u2122 and/or at MRI,\n           targeted biopsies will be performed in the suspicious part of the sextant (at least two\n           cores per suspicious lesion).\n\n        -  Histoscanning\u2122 and MRI results will be compared to biopsy results.\n\n      A total of 30 patients will be included"
        }, 
        "brief_title": "Post-radiation Prostate Cancer Local Recurrences: Detection With Histoscanning\u2122 and MRI", 
        "condition": "Prostate Cancer Recurrent", 
        "condition_browse": {
            "mesh_term": [
                "Prostatic Neoplasms", 
                "Recurrence"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with biochemical recurrence (Phoenix criteria: PSA nadir + 2 ng/ml) after\n             radiation therapy for prostate cancer addressed for prostate biopsy OR Patients\n             referred to our institution for biopsy-proven local recurrence after radiation\n             therapy for prostate cancer but needing a re-assessment with biopsy (insufficient\n             number of biopsy and/or imprecise location of positive biopsy and/or questionable\n             diagnostic of recurrence)\n\n          -  IRB-approved informed consent signed\n\n        Exclusion Criteria:\n\n          -  Contraindication to MRI\n\n          -  Contraindication to endorectal examination\n\n          -  Contraindication to prostate biopsy\n\n          -  History of allergy to gadolinium chelates"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 28, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01857037", 
            "org_study_id": "2010.655"
        }, 
        "intervention": {
            "arm_group_label": "Single arm", 
            "description": "Detection and localization of prostate cancer local recurrences after radiation therapy using Histoscanning\u2122 and multiparametric MRI", 
            "intervention_name": "Histoscanning\u2122 and multiparametric MRI", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 15, 2013", 
        "location": {
            "contact": {
                "email": "Olivier.rouviere@netcourrier.com", 
                "last_name": "Olivier Rouvi\u00e8re, Pr", 
                "phone": "+33(0)472110951"
            }, 
            "facility": {
                "address": {
                    "city": "Lyon", 
                    "country": "France", 
                    "state": "Rh\u00f4ne", 
                    "zip": "69437"
                }, 
                "name": "Prof O. ROUVIERE"
            }, 
            "investigator": [
                {
                    "last_name": "Matthieu PAPILLARD, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Albert GELET, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "S\u00e9bastien CROUZET, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "1", 
        "official_title": "Detection and Localization of Prostate Cancer Local Recurrences After Radiation Therapy Using Histoscanning\u2122 and Multiparametric MRI", 
        "overall_contact": {
            "email": "Olivier.rouviere@netcourrier.com", 
            "last_name": "Olivier Rouvi\u00e8re, Pr", 
            "phone": "+33 (0)472 11 09 51"
        }, 
        "overall_official": {
            "affiliation": "Hospices Civiles de Lyon", 
            "last_name": "Olivier Rouvi\u00e8re, Pr", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Afssaps - Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9 (Saint-Denis)", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Histoscanning and biopsy findings will be compared on a sextant by sextant basis. A mixed effects logistic regression model (with fixed and random effects) will be used to model the sensitivity and specificity of Histoscanning to correctly identify the presence or absence of cancer into prostate sextants.", 
            "measure": "Evaluation of Histoscanning\u2122 after radiation therapy in comparison to random and targeted biopsy.", 
            "safety_issue": "No", 
            "time_frame": "1 day"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01857037"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "MRI and biopsy findings will be compared on a sextant by sextant basis. A mixed effects logistic regression model (with fixed and random effects) will be used to model the sensitivity and specificity of MRI to correctly identify the presence or absence of cancer into prostate sextants.", 
            "measure": "Evaluation of multiparametric MRI after radiation therapy in comparison to random and targeted biopsy.", 
            "safety_issue": "No", 
            "time_frame": "1 day"
        }, 
        "source": "Hospices Civils de Lyon", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hospices Civils de Lyon", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2011", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "April 2011"
    }
}